Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "KRYSTAL-1 Trial - Activity & Safety of Adagrasib in Patients with Advanced Solid Tumors Harboring a KRASG12C Mutation"

92 views
June 21, 2023
Comments 1
Login to view comments. Click here to Login